Put New Aimovig for Migraine Prophylaxis Into Perspective

August 2018

You'll hear buzz about Aimovig (AIM-oh-vig, erenumab), a new biologic to PREVENT migraine in adults.

It blocks receptors for calcitonin gene-related peptide (CGRP)...a vasodilator and pain sensitizer that spikes during migraine attacks.

Expect other "CGRP antagonists" to be approved within a few months.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Nephrology Optimize Meds in Chronic Kidney Disease
Antibiotics Clear Up Confusion About Nitrofurantoin
Influenza Explain Why FluMist Is Back for the 2018-19 Flu Season
Heart Failure Be Familiar With the Role of Nonstandard Heart Failure Meds
Migraine Put New Aimovig for Migraine Prophylaxis Into Perspective
Hypertension Be Ready to Use More Than One BP Med to Treat Hypertension
Neurology & Pain Balance Risks and Benefits of Gabapentin and Pregabalin
Dermatology Sort Through Treatments for Sunburns and Other Minor Burns
Opioids Ensure Opioid Intolerance Is Documented Correctly
Insulin Don't Buy Into Marketing That Toujeo Max SoloStar Will Save Money